Literature DB >> 26946464

STAT order: Should patients with chronic liver disease be prescribed statins to prevent fibrosis progression and hepatocellular carcinoma?

Juan G Abraldes1, Kelly W Burak2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26946464     DOI： 10.1002/hep.28537

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  4 in total

Review 1.  The Use of Statins in Patients With Chronic Liver Disease and Cirrhosis.

Authors:  Carlos Moctezuma-Velázquez; Juan G Abraldes; Aldo J Montano-Loza
Journal:  Curr Treat Options Gastroenterol       Date:  2018-06

Review 2.  Statins Show Promise Against Progression of Liver Disease.

Authors:  Prashanth Francis; Lisa M Forman
Journal:  Clin Liver Dis (Hoboken)       Date:  2021-12-20

Review 3.  Pleiotropic effects of statins in the diseases of the liver.

Authors:  Martin Janicko; Sylvia Drazilova; Daniel Pella; Jan Fedacko; Peter Jarcuska
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

4.  Coenzyme Q10 or Creatine Counteract Pravastatin-Induced Liver Redox Changes in Hypercholesterolemic Mice.

Authors:  Ana C Marques; Estela N B Busanello; Diogo N de Oliveira; Rodrigo R Catharino; Helena C F Oliveira; Anibal E Vercesi
Journal:  Front Pharmacol       Date:  2018-06-27       Impact factor: 5.810
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.